Skip to main content
logo
Abera Bioscience AB (NGM:ABERA)
Sweden flag Sweden · Delayed Price · Currency is SEK
8.22
-0.18 (-2.14%)
At close: Aug 14, 2026

Abera Bioscience AB Revenue

Abera Bioscience AB had revenue of 3.55M SEK in the quarter ending March 31, 2026, a decrease of -0.59%. This brings the company's revenue in the last twelve months to 11.83M, down -25.75% year-over-year. In the year 2025, Abera Bioscience AB had annual revenue of 11.85M, down -18.99%.

Revenue (ttm)
11.83M
Revenue Growth
-25.75%
P/S Ratio
14.24
Revenue / Employee
1.97M
Employees
6
Market Cap
168.50M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202511.85M-2.78M-18.99%
Dec 31, 202414.63M12.11M479.60%
Dec 31, 20232.52M736.19K41.18%
Dec 31, 20221.79M609.91K51.78%
Dec 31, 20211.18M422.43K55.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Xbrane Biopharma AB83.30M
Nanologica AB31.83M
Alzinova AB25.66M
Biovica International AB13.49M
Elicera Therapeutics AB10.64M
NextCell Pharma AB9.24M
Simris Group AB (PUBL)3.59M
Xintela AB2.59M
Revenue Rankings

Abera Bioscience AB News

More News